In line with these studies, the conditional deletion of Jam-C before induction of AML using the iMLL-AF9 oncogene resulted in a shift from LT- to ST-HSC expansion, without affecting disease initiation and progression [148]. Here, JAM3 is linked to acute myeloid leukemia.